Quantification of Antiviral Cytokines in Serum, Cerebrospinal Fluid and Urine of Patients with Tick-Borne Encephalitis in Croatia.
cerebrospinal fluid
cytokines
serum
tick-borne encephalitis
urine
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
29 Oct 2022
29 Oct 2022
Historique:
received:
29
09
2022
revised:
24
10
2022
accepted:
26
10
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
12
11
2022
Statut:
epublish
Résumé
Tick-borne encephalitis virus (TBEV) is one of the most significant arboviruses affecting the human central nervous system (CNS) in Europe. Data on cytokine response in TBEV infection are limited. We analyzed the cytokine response in serum, cerebrospinal fluid (CSF) and urine samples of patients with TBE. The control group consisted of patients with 'febrile headache' who had normal CSF cytology. The panel included 12 cytokines: TNF-α, IL-6, Th1 (IL-2, IFN-γ), Th2 (IL-4, IL-5, IL-13), Th9 (IL-9), Th17 (IL-17A, IL-17F), Th22 (IL-22) cytokines and IL-10. TBE patients were more likely to have increased levels of IL-6 and IFN-γ in CSF compared to controls (85.7% vs. 58.8% and 85.7% vs. 47.1%, respectively). However, concentrations of IL-6 (the most abundant cytokine in the CSF of both groups), IL-10 and IL-9 were lower in TBEV patients compared with controls, but the difference was statistically significant for IL-9 only ( Cytokine composition in different clinical samples of TBE patients reveals a different network of early innate immune response cytokines, Th1, Th2, Th9, Th22, Th17 and anti-inflammatory cytokines.
Sections du résumé
BACKGROUND
BACKGROUND
Tick-borne encephalitis virus (TBEV) is one of the most significant arboviruses affecting the human central nervous system (CNS) in Europe. Data on cytokine response in TBEV infection are limited.
METHODS
METHODS
We analyzed the cytokine response in serum, cerebrospinal fluid (CSF) and urine samples of patients with TBE. The control group consisted of patients with 'febrile headache' who had normal CSF cytology. The panel included 12 cytokines: TNF-α, IL-6, Th1 (IL-2, IFN-γ), Th2 (IL-4, IL-5, IL-13), Th9 (IL-9), Th17 (IL-17A, IL-17F), Th22 (IL-22) cytokines and IL-10.
RESULTS
RESULTS
TBE patients were more likely to have increased levels of IL-6 and IFN-γ in CSF compared to controls (85.7% vs. 58.8% and 85.7% vs. 47.1%, respectively). However, concentrations of IL-6 (the most abundant cytokine in the CSF of both groups), IL-10 and IL-9 were lower in TBEV patients compared with controls, but the difference was statistically significant for IL-9 only (
CONCLUSIONS
CONCLUSIONS
Cytokine composition in different clinical samples of TBE patients reveals a different network of early innate immune response cytokines, Th1, Th2, Th9, Th22, Th17 and anti-inflammatory cytokines.
Identifiants
pubmed: 36366333
pii: vaccines10111825
doi: 10.3390/vaccines10111825
pmc: PMC9698853
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Croatian Science Foundation
ID : HRZZ IP-2016-06-7456
Organisme : School of Medicine, University of Zagreb, Croatia
ID : 10106-22-3053
Références
J Med Virol. 2015 May;87(5):885-92
pubmed: 25675945
Infect Ecol Epidemiol. 2011;1:
pubmed: 22957110
Vaccine. 2003 Apr 1;21 Suppl 1:S36-40
pubmed: 12628812
Adv Med Sci. 2011;56(2):311-7
pubmed: 22008312
Autoimmun Rev. 2017 Dec;16(12):1209-1218
pubmed: 29037907
J Neuroinflammation. 2017 Jun 24;14(1):126
pubmed: 28646884
Int J Infect Dis. 2020 Apr;93:40-47
pubmed: 31978584
Clin Exp Immunol. 2003 Jan;131(1):148-54
pubmed: 12519399
Pathogens. 2021 Jan 15;10(1):
pubmed: 33467617
Pediatr Infect Dis J. 2016 Sep;35(9):961-6
pubmed: 27187756
Przegl Epidemiol. 2020;74(2):316-325
pubmed: 33115220
J Neurovirol. 2021 Jun;27(3):452-462
pubmed: 33876413
Exp Mol Pathol. 2015 Dec;99(3):570-4
pubmed: 26216406
Pathogens. 2022 Jan 02;11(1):
pubmed: 35056000
Viruses. 2021 Feb 22;13(2):
pubmed: 33671821
Int J Mol Sci. 2022 Aug 19;23(16):
pubmed: 36012596
Immunology. 2021 Sep;164(1):73-89
pubmed: 33876425
Immune Netw. 2020 Nov 18;20(6):e45
pubmed: 33425430
PLoS One. 2012;7(8):e44153
pubmed: 22952908
Antiviral Res. 2019 Apr;164:23-51
pubmed: 30710567
Acta Neurol Scand. 2007 Feb;115(2):109-14
pubmed: 17212614
Ticks Tick Borne Dis. 2020 Nov;11(6):101513
pubmed: 32993933
Pathogens. 2022 Jun 18;11(6):
pubmed: 35745558
Annu Rev Immunol. 2017 Apr 26;35:53-84
pubmed: 27912316
Microorganisms. 2019 Oct 31;7(11):
pubmed: 31683598
Methods Enzymol. 2019;629:151-176
pubmed: 31727238
J Immunol. 2020 Feb 1;204(3):531-539
pubmed: 31852750
Int J Infect Dis. 2020 Jan;90:104-110
pubmed: 31678190
Ticks Tick Borne Dis. 2020 Sep;11(5):101467
pubmed: 32723646
J Neuroinflammation. 2016 Oct 18;13(1):273
pubmed: 27756335
Immunity. 2011 Feb 25;34(2):149-62
pubmed: 21349428
J Virol. 2016 Dec 16;91(1):
pubmed: 27795421
J Neuroinflammation. 2018 Apr 20;15(1):115
pubmed: 29678185
Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1218-27
pubmed: 27016501
Pol J Microbiol. 2016;65(1):119-21
pubmed: 27282004
Emerg Infect Dis. 2022 Feb;28(2):291-301
pubmed: 35075993
Trop Med Infect Dis. 2020 Sep 14;5(3):
pubmed: 32937866
J Clin Med. 2019 May 22;8(5):
pubmed: 31121969
Emerg Microbes Infect. 2022 Dec;11(1):1647-1656
pubmed: 35657098
World J Clin Cases. 2015 May 16;3(5):430-41
pubmed: 25984517
BMC Infect Dis. 2014 Nov 18;14:614
pubmed: 25403498